[1]
F. Alenezi, C. Girard, D. Bessis, B. Guillot, A. Du-Thanh, and O. Dereure, “Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome”, Acta Derm Venereol, vol. 101, no. 2, p. adv00384, Feb. 2021.